Welcome to our dedicated page for Nature's Sunshine Products news (Ticker: NATR), a resource for investors and traders seeking the latest updates and insights on Nature's Sunshine Products stock.
Nature's Sunshine Products Inc. (NASDAQ: NATR) is a leading natural health and wellness company that manufactures and markets an extensive range of high-quality nutritional and personal care products. Founded in 1972, the company has established itself as a pioneer in the health and wellness industry, offering products such as tablets, encapsulated herbal products, natural vitamins, food supplements, skin care items, and other complementary products.
The company operates on a direct-selling model and has a significant presence in multiple international markets, including but not limited to the United States, South Korea, Mexico, Venezuela, Japan, Brazil, Canada, Central America, Colombia, Ecuador, Peru, the United Kingdom, Israel, and Chile. Additionally, it exports its products to countries such as Argentina, Australia, Malaysia, New Zealand, Norway, and the Russian Federation.
Nature's Sunshine focuses on various health categories, including weight management, general health, cardiovascular health, digestive health, immune support, and personal care. The company's operations are divided into four main segments: Asia, Europe, North America, and Latin America, with Asia being the key revenue-generating market.
Recent achievements highlight the company's robust financial performance. In the latest fiscal reports, Nature's Sunshine recorded net sales up by 12% to $116.5 million, with a 14% increase in constant currency. The third quarter of 2023 saw a GAAP net income rise to $3.1 million and a 50% increase in Adjusted EBITDA to $10.3 million. The company's CEO, Terrence Moorehead, emphasized strong growth in both the Asia/Pacific and North American markets, which contributed to a 12% and 11% increase in local currency sales, respectively.
Nature’s Sunshine's gross margin improved by 150 basis points to 73.1% in Q3 2023 compared to the previous year. These improvements were attributed to market mix enhancements, price increases, and margin improvement initiatives. Selling, general, and administrative expenses (SG&A) rose to $41.3 million due to increased service fees in China, compensation, and investments in digital growth and strategic initiatives.
The company also announced a series of conference calls to discuss its quarterly and annual financial results, providing transparency and updates to shareholders and potential investors. Nature’s Sunshine’s commitment to high-quality, safe, and effective products is evident through its state-of-the-art manufacturing facilities, ensuring products meet the highest standards.
The company's outlook for the future remains positive, with expectations for continued growth in net sales and adjusted EBITDA, driven by strategic initiatives and digital investments designed to enhance market presence and customer engagement.
Nature's Sunshine Products (NASDAQ: NATR) has appointed Tariq H. Hassan to its board of directors, effective July 1, 2021. With over 25 years of global brand strategy and management experience, Hassan will also join the Audit Committee, expanding the board to nine members, eight of whom are independent directors. Previously, he served as Chief Marketing Officer at Petco, leading significant growth initiatives. His expertise in consumer marketing and digital implementation aligns with Nature's Sunshine's ongoing business transformation and five-point growth strategy.
Nature’s Sunshine Products (NASDAQ: NATR), a leader in natural health, will present at Stifel’s Cross Sector Insight Conference from June 8-10, 2021. Management is set to present on June 9 at 4:00 p.m. Eastern time, with one-on-one meetings available throughout the day. The presentation will be accessible via live webcast and later replay. Nature’s Sunshine is recognized for its high-quality herbal and nutritional products, manufacturing most of its items in-house to ensure safety and efficacy. More information can be found on their website.
Nature's Sunshine Products (Nasdaq: NATR) announced a new scholarship initiative in partnership with the David Eccles School of Business at the University of Utah. The company pledged $200,000 over four years, with the Eccles School matching 50%, totaling $300,000 for full-ride scholarships aimed at diverse, underrepresented students aiming for their first college degree. This effort aligns with the company's commitment to support education, particularly in disadvantaged communities, and stems from their Stronger Together initiative focused on promoting diversity and inclusiveness.
Xenia Hotels & Resorts announced the appointment of Terrence Moorehead to its Board of Directors, effective May 25, 2021. This increases the Board to nine members, with eight being independent. Moorehead, CEO of Nature's Sunshine Products, brings expertise in high-end consumer products and health and wellness, relevant to Xenia's upscale lodging focus. His diverse experience includes executive roles at Avon and other companies. Moorehead expressed enthusiasm about joining Xenia and aims to enhance shareholder value through collaboration with the management team.
Nature's Sunshine (NASDAQ: NATR) is set to launch a new personalization program in North America, allowing practitioners and retailers to offer customized health packs. This initiative is part of the company's digital transformation and strategic roadmap aimed at enhancing business growth. The program is designed to improve customer experience by providing monthly, pre-sorted packs tailored to individual health needs, and has already contributed to record sales over the last three quarters. The service will be free of charge and aims to strengthen the company's relationship with its practitioners.
Nature’s Sunshine Products reported record net sales of $102.4 million for Q1 2021, a 7% increase from the previous year. GAAP net income rose to $4.2 million or $0.20 per diluted share, compared to $3.0 million or $0.15. Non-GAAP net income per diluted share also increased to $0.21. Adjusted EBITDA surged 20% to $11.6 million. Key markets driving growth included Asia and Latin America, while North America faced challenges due to pandemic stockpiling. Operating income slightly improved to 7.5% of net sales, and the company maintained strong cash reserves of $91.3 million.
Nature’s Sunshine Products (NASDAQ: NATR) will host a conference call on May 6, 2021, at 5:00 p.m. Eastern time to discuss its financial results for Q1 2021, ending March 31, 2021. CEO Terrence Moorehead and CFO Joseph Baty will lead the call, which includes a Q&A session. Investors can join the call by dialing the provided numbers and are encouraged to register 5-10 minutes before the start. A replay will be accessible following the call through May 20, 2021. For more information, please visit Nature’s Sunshine website.
Nature’s Sunshine Products (Nasdaq: NATR) reported a powerful fourth quarter for 2020, achieving record net sales of $101.7 million, a 11% increase from the previous year. GAAP net income soared 445% to $6.7 million, equivalent to $0.29 per diluted share. The company declared a special cash dividend of $1.00 per share and announced a $15 million share repurchase program. Full-year sales reached $385.2 million, marking a 6% increase from 2019. Despite increased SG&A expenses, the firm continues to prioritize financial stability and future growth initiatives.
Nature’s Sunshine Products (NASDAQ: NATR) will host a conference call on March 10, 2021, at 5:00 p.m. Eastern time to discuss its fourth-quarter and full-year financial results for 2020. CEO Terrence Moorehead and CFO Joseph Baty will lead the call, which includes a Q&A session. Participants can join the call using the provided toll-free and international dial-in numbers. A replay will be available until March 24, 2021. Nature’s Sunshine operates in over 40 countries, manufacturing high-quality nutritional and personal care products.
Nature’s Sunshine Products (Nasdaq: NATR) announced a record net sales of $100.3 million for the third quarter of 2020, marking a 13% increase from the previous year. GAAP net income rose significantly to $7.2 million or $0.34 per diluted share. Adjusted EBITDA also increased by 13% to $9.4 million.
The growth was fueled by robust consumer demand, new product launches, and easing COVID-19 restrictions in key markets, particularly in U.S. and China. The company aims to further enhance customer engagement and support distributors as part of its business transformation initiatives.
FAQ
What is the current stock price of Nature's Sunshine Products (NATR)?
What is the market cap of Nature's Sunshine Products (NATR)?
What does Nature's Sunshine Products Inc. do?
What are the main health categories that Nature's Sunshine focuses on?
In which regions does Nature's Sunshine operate?
How is Nature's Sunshine’s financial performance?
What are the key revenue-generating markets for Nature's Sunshine?
What recent achievements has Nature's Sunshine made?
How does Nature's Sunshine ensure the quality of its products?
What strategic initiatives is Nature's Sunshine focusing on?
What is Nature's Sunshine's outlook for the future?
How can I get more information about Nature’s Sunshine?
